These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6673206)

  • 1. Capping experiments fail to reveal H-2Rd molecules in Dd region.
    Ivanyi D; Demant P
    Transplant Proc; 1983 Dec; 15(4):2039-41. PubMed ID: 6673206
    [No Abstract]   [Full Text] [Related]  

  • 2. Flow microfluorometric analysis of H-2L expression.
    Potter TA; Hansen TH; Habbersett R; Ozato K; Ahmed A
    J Immunol; 1981 Aug; 127(2):580-4. PubMed ID: 6788845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in expression of MHC products between several H-2-restricted CTL clones.
    Hauptfeld V; Braciale TJ; Shreffler DC
    J Immunol; 1982 May; 128(5):2026-31. PubMed ID: 6977581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H-2 and viral haemagglutinin expression by influenza-infected cells; the proteins are close but do not cocap.
    Hackett CJ; Askonas BA
    Immunology; 1982 Mar; 45(3):431-8. PubMed ID: 6977485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC-coded unique alloantigens and antitumor immunity.
    Martin WJ
    Transplant Proc; 1981 Dec; 13(4):1837-40. PubMed ID: 7036480
    [No Abstract]   [Full Text] [Related]  

  • 6. Private specificity of H-2Ldx molecule detected serologically by a surface antigen redistribution method (capping).
    Ivány D; Démant P
    Tissue Antigens; 1982 Oct; 20(4):274-81. PubMed ID: 6183786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of specific unresponsiveness using transfected cells expressing donor major histocompatibility complex molecules: evidence for indirect presentation of allopeptides in vivo.
    Bell Y; Shoskes D; Morris P; Wood K
    Transplant Proc; 1993 Feb; 25(1 Pt 1):359. PubMed ID: 8438334
    [No Abstract]   [Full Text] [Related]  

  • 8. Functional heterogeneity of H-2Dk-region products.
    Démant P; Iványi D; Fischer-Lindahl K
    Immunogenetics; 1981; 13(5):457-61. PubMed ID: 7298088
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of at least two distinct mouse I-E antigen molecules by the use of a monoclonal antibody.
    Ozato K; Sachs DH
    J Immunol; 1982 Feb; 128(2):807-10. PubMed ID: 6948041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex.
    Ozato K; Hansen TH; Sachs DH
    J Immunol; 1980 Dec; 125(6):2473-7. PubMed ID: 7191868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental allergic encephalomyelitis (EAE) in mice: primary control of EAE susceptibility is outside the H-2 complex.
    Montgomery IN; Rauch HC
    J Immunol; 1982 Jan; 128(1):421-5. PubMed ID: 7054282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody detection of two classes of H-2Kk molecules.
    O'Neill HC; Parish CR
    Mol Immunol; 1981 Aug; 18(8):713-22. PubMed ID: 6171726
    [No Abstract]   [Full Text] [Related]  

  • 13. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in histocompatibility antigen expression on murine tumors: differences in expression and immunogenicity of H-2K region-coded unique antigens.
    Imamura M; Martin WJ
    J Immunol; 1982 Aug; 129(2):877-81. PubMed ID: 7086147
    [No Abstract]   [Full Text] [Related]  

  • 15. The cytoplasmic and the transmembrane domains are not sufficient for class I MHC signal transduction.
    Gur H; Geppert TD; Wacholtz MC; Lipsky PE
    Cell Immunol; 1999 Feb; 191(2):105-16. PubMed ID: 9973532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression.
    Ozato K; Sachs DH
    J Immunol; 1981 Jan; 126(1):317-21. PubMed ID: 6935293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alloreactive monoclonal antibodies select Kd molecules with different peptide profiles.
    Noun G; Reboul M; Abastado JP; Jaulin C; Kourilsky P; Pla M
    J Immunol; 1996 Sep; 157(6):2455-61. PubMed ID: 8805645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage MHC receptor 2: a novel receptor on allograft (H-2D(d)K(d))-induced macrophage (H-2D(b)K(b)) recognizing an MHC class I molecule, H-2K(d), in mice.
    Tashiro-Yamaji J; Kubota T; Yoshida R
    Gene; 2006 Dec; 384():1-8. PubMed ID: 17010536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-MHC-linked genetic control of murine cytotoxic T lymphocyte responses to hapten-modified syngeneic cells.
    Arora PK; Shearer GM
    J Immunol; 1981 Nov; 127(5):1822-8. PubMed ID: 6975299
    [No Abstract]   [Full Text] [Related]  

  • 20. Foreign H-2-like alloantigens of syngeneic tumor cells can act as new "restriction" molecules for the associative recognition of non-H-2 or tumor-associated antigens by lymphoid effectors in the cytostasis assay.
    Festenstein H; de Giorgi L; Matossian-Rogers A
    Transplant Proc; 1981 Dec; 13(4):1877-9. PubMed ID: 7330973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.